ID   BJAB-B95.8.6
AC   CVCL_B6UM
DR   cancercelllines; CVCL_B6UM
DR   Wikidata; Q111732959
RX   PubMed=2995242;
RX   PubMed=3872842;
RX   PubMed=8449221;
CC   Population: African; Kenyan.
CC   Virology: EBV-negative cell line infected with EBV strain B95-8.
CC   Karyotypic information: 45,XX,-8,3q+,7p+,8q+,10p+,11p+,inv(13) (PubMed=2995242).
CC   Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.His193Arg (c.578A>G); ClinVar=VCV000184979; Zygosity=Unspecified (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Groin; UBERON=UBERON_0008337.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5711 ! BJAB
SX   Female
AG   5Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 02-05-24; Version: 7
//
RX   PubMed=2995242; DOI=10.1016/S0171-2985(85)80001-2;
RA   Ziegler A., Muller C., Heinig J., Radka S.F., Kompf J., Fonatsch C.;
RT   "Monosomy 6 in a human lymphoma line induced by selection with a
RT   monoclonal antibody.";
RL   Immunobiology 169:455-460(1985).
//
RX   PubMed=3872842; DOI=10.1007/BF00375380;
RA   Spring B., Fonatsch C., Muller C., Pawelec G., Kompf J., Wernet P.,
RA   Ziegler A.;
RT   "Refinement of HLA gene mapping with induced B-cell line mutants.";
RL   Immunogenetics 21:277-291(1985).
//
RX   PubMed=8449221; DOI=10.1002/eji.1830230325;
RA   Uchanska-Ziegler B., Noessner E., Schenk A., Ziegler A., Schendel D.J.;
RT   "Soluble T cell receptor-like properties of an HLA-B35-specific
RT   monoclonal antibody (TU165).";
RL   Eur. J. Immunol. 23:734-738(1993).
//